(Q39995744)

16 September 2017

Paclitaxel and cisplatin as intravesical agents against non-muscle-invasive bladder cancer (English)

1 reference

16 September 2017

1 reference

1 reference

Boris A Hadaschik

1

0 references

Helen M. Burt

object named as

Helen M Burt

6

0 references

author name string

Melanie G ter Borg

2

1 reference

16 September 2017

John Jackson

3

1 reference

16 September 2017

Richard D Sowery

4

1 reference

16 September 2017

Alan I So

5

1 reference

16 September 2017

Martin E Gleave

7

1 reference

16 September 2017

language of work or name

1 reference

2 April 2008

1 reference

16 September 2017

1 reference

16 September 2017

101

1 reference

16 September 2017

1347-1355

1 reference

16 September 2017

11

1 reference

Bladder cancer: epidemiology, staging and grading, and diagnosis.

16 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07571.X

The treated natural history of high risk superficial bladder cancer: 15-year outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07571.X

Is intravesical chemotherapy for superficial bladder cancer still justified?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07571.X

Apparent failure of current intravesical chemotherapy prophylaxis to influence the long-term course of superficial transitional cell carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07571.X

Update on chemotherapy for advanced bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07571.X

A validated mouse model for orthotopic bladder cancer using transurethral tumour inoculation and bioluminescence imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07571.X

Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07571.X

A third-generation bisphosphonate, minodronic acid (YM529), successfully prevented the growth of bladder cancer in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07571.X

Prediction of drug combination chemosensitivity in human bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07571.X

Local drug delivery to bladder using technology innovations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07571.X

10.1111/J.1464-410X.2008.07571.X

21 January 2018

Identifiers

DOI

1 reference

16 September 2017

1 reference